I am an independent investor helping retail investors beat Wall Street to undiscovered high technology and biotechnology growth stocks.
University of Michigan (1987) - Bachelors Degree in Business, Professional Accounting, Finance and Managerial Economics
Michigan State University School of Law (1994) - Area of Practice Medical-Legal Cases
I am a US Air Force Academy graduate and pilot. I have a Bachelors of Science in Economics. I flew KC-135 tankers and also worked as the budget officer in the comptroller’s squadron. I started off my civilian career as a stock broker for Dean Witter. After leaving Dean Witter I worked at a regional Broker Dealer called National Securities. I was a research analyst and authored and published reports in the aerospace sector. I am no stranger to public speaking and was a guest professor at the local community college teaching about the stock and options markets. In 1999 I left the securities business to test my skills as an entrepreneur.
Currently I work as a contract CFO for various public companies.
Avisol Capital Partners runs the Total Pharma Tracker Seeking Alpha Marketplace service. This is managed by Dr Asok Dutta, BVScAH and Dr Udaya Kumar Maiya, MD Oncologist. The service offers end-to-end research on both investing and trading ideas everyday, and includes a 150-stock watchlist and two 40-stock model portfolios that are continuously tracked.
Dr Dutta is a retired veterinary surgeon. He has over 40 years experience in the industry. Dr Maiya is a well-known oncologist who has 30 years in the medical field, including as Medical Director of various healthcare institutions. Both doctors are also avid private investors. They are assisted by a number of finance professionals in developing this service.
If you want to check out our service, go here - https://seekingalpha.com/author/avisol-capital-partners/research
Disclaimer - we are not investment advisors.
Our news team's weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks.
Biotech investor focusing primarily on small and mid-cap biotech companies and using the public available information, including publications, financial statements, events news, and secondary research. Gang is currently a senior scientist for a biotech company based on New York and brings a solid chemistry background as well as financial knowledge as a contributor. Previously, Gang was a reviewer and research fellow in US FDA and Ph.D. from University of Missouri with primary researches on analytical method development of small molecule drug analysis
Formerly a Wall Street executive from a premier investment bank, author EXP's goal is to help investors discover stocks before the "crowd." The first article published was on "LNG" many years ago; an undiscovered gem. BLOG: https://seekingalpha.com/account/authorboard/instablog
This is not an easy business. Investing is psychological in nature and can be extremely taxing. Patience is key. Not all ideas are written about or picked for publication.
EXP works hard to identify and write about current stock opportunities in the market that can produce some huge gains from disconnects in stock prices. These inefficiencies can be taken advantage of if you can properly identify opportunities, and then manage to act on them before the crowd.
EXP resides in the USA and is very thankful to followers worldwide.
You can also follow EXPstocktrader on: Twitter --- @EXPstocktrader Email --- email@example.com >>>
Disclosure: The administrator(s) of the services mentioned here may be long, short, or flat in any position mentioned as disclosed. All statements are made without any representation to its complete accuracy and administrator(s) are not compensated for posting notes by listed companies. Some minimal compensation is paid by SA if the article gets picked for circulation. EXP never takes money from companies to promote or write about a stock. All stock prices shown are approximate. Ratings may change at any time. All posts are for simulation purposes only. All stock trades transacted by you are at your own risk. We trade stocks and do not usually buy and hold indefinitely. Please take any information that you see here and consult your own investment advisor before making any real trades. EXP, EXPstocktrader and Seeking Alpha are Not licensed to give you investment advice based on your own personal suitability and risk tolerances. Please consult with your financial advisor before making any trades that you read about here or anywhere EXPstocktrader publishes information for that matter. Thank you.
I'm the founder of Seeking Alpha. I led it for its first 10 years until 2015. Two years later, I returned to Seeking Alpha to run product, which is the aspect of my work as a founder I most loved. I started Seeking Alpha after working for five years as a technology research analyst for Morgan Stanley in New York. After I left, I wrote The ETF Investing Guide (which you can find by clicking on "Author's Picks" below), and some articles about individual stocks, and then started inviting other people to contribute to the website. Seeking Alpha is now the dominant crowdsourced platform for discussion of stocks and investing, and the only place with coverage of many mid and small cap stocks. I have a B.A from Oxford University and an MSc from The London School of Economics, and am married with five children.
Seeking Alpha's product team is responsible for the development of all of our product-related projects from start to finish. These projects include the Seeking Alpha Portfolio apps on the App Store and Google Play, our Real Time email alert product, and optimization across the Seeking Alpha website.
The purpose of this profile is to allow us to share with our readers all new product developments. Please follow us on Seeking Alpha to receive updates. We look forward to your input and feedback!
SA Product Team
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
Robert Hauver, MBA, is a Registered Investment Advisor Representative., who publishes SA articles under the name
TipRanks rates DoubleDividendStocks in the Top 25 of all financial bloggers, and Seeking Alpha rates us in the Top 5 of several categories, including Dividend Ideas, Basic Materials, and Utilities.
We offer 2 investing services:
"Hidden Dividend Stocks Plus", a new Seeking Alpha Marketplace service, which focuses on undercovered and undervalued income vehicles. HDS+ scours the world's markets to find solid income opportunities with dividend yields ranging from 5% to 10%-plus, backed by strong earnings.
DoubleDividendStocks.com, an investment newsletter/website that features the best dividend stocks and option selling strategies for income investors looking to enhance their yields.
The https://www.DoubleDividendStocks.com website also features High Dividend Stocks By Sector Tables, Covered Calls and Cash Secured Puts Tables, a Dividend Stocks blog, and a a Stock Market News and Data pages. 845-225-4094
Climate Researcher & Modeler with 32 years in Strategic Planning &
Prior: Academic background --
Private Sector background --
Carbon Dioxide is a gas whose importance is greatly misunderstood and I am going to try to describe and explain a more detailed survey of Earth's Dynamic Climate than the 'oversimplified' CO2 '1-Size-Fits-All-Issues' rhetoric that has been fed to the public. Not my favorite task, but a worthwhile one -- hopefully.
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------NEW UPDATE 9/25/2017
September 25. 2017: I realize that I should be providing the scientific information that people expect of me. I have been slow to getting this organized due to both my health and because I have to post whatever is here without anyone else being considered responsible for the content. In the future I will attempt to provide more answers to Environmental questions regarding important topics not necessarily directly connected to investing. If you have any Climatic or Environmental questions please do not hesitate to ask. Don't let my poor writing skills discourage you if you have questions. To type even this small update required more physically than I can routinely accomplish. New accessibility enhanced equipment is something I will be installing to aid in this purpose. Thank you for your patience. lwp
BARGE DELIVERED COAL=SULFURIC ACID RUN-OFF INTO RIVERS
Coal ruins the water quality as well as air, due to the run-off it creates which has an ultra low PH. In essence, that's how you make 'Sulfuric Acid'. Not good for rivers and barge delivered coals makes this inevitable. Bear in mind that the average Coal plant in the Ohio River, say 'Ghent' [between Cincinnati and Louisville] maintains a 100 'Burn Day' inventory. Ghent burns 14,000 tons of coal daily. 1.4 million tons sits adjacent to the Ohio River, in the rain, waiting to be used.
WATER AS WELL AS AIR IS CONTAMINATED BY COAL!
After rainfalls, rivulets of 'Sulfuric Acid' give birth to ephemeral streams that erode the ground as they make their way into the Ohio, just a few meters away. The rest simply goes into the water table and contaminates the 'Aquifer Recharge zone'. Small wonder so many Kentucky rural communities have municipal water rather than wells. CO2
REDUCTION IS IMPORTANT BUT THERE'S MORE THAN JUST CO2 TO REDUCE!
John Thomas is a 50-year veteran of the financial markets. He spent 10 years as a financial journalist, ten more years trading for a major investment bank, and another decade running the first dedicated international hedge funds. Seeing the incredible inefficiencies and severe mispricing offered by the popping of multiple bubbles during the Great Crash of 2008, and missing the adrenaline of the marketplace, he returned to active hedge fund management.
With The Diary of a Mad Hedge Fund Trader, his goal is to broaden public understanding of the techniques and strategies employed by the most successful hedge funds so that they may more profitably manage their own money.
He publishes a daily research newsletter, and offers one of the most successful trade mentoring services in the industry. He currently has followers in 134 countries.
In his free time, John Thomas climbs mountains, does long distance backpacks, practices karate, performs aerobatics in antique aircraft, collects vintages wines, reads the Japanese classics, and engages in a wide variety of public service and philanthropic activities.
His career has taken him up to 20,000 feet on Mount Everest, to the edge of space at 90,000 feet in the Cockpit of a MIG-25, and to the depths of a sunken Japanese fleet in the Truk Lagoon.
Why they call him "Mad" he will never understand.
David Zanoni is ranked in the top 1% of blogging analysts on Tipranks.com for performance and accuracy. He focuses on growth & momentum stocks that are reasonably priced and likely to outperform the market over the long-term. David is a graduate of Rutgers University with a B.S. in Management. He is an independent long term investor of quality stocks and uses options for strategy. David believes in the power of innovation, capitalism, and the characteristics of the American spirit: intellect, fortitude, and adaptability to lead our country and the world to growing prosperity. His wants to help make people money by investing in high-quality growth stocks.
2016 returns: 22.40%
2017 returns: 22.05%
The REIT Forum is in the top 1% on TipRanks: http://bit.ly/cwmftip
The REIT Forum focuses on risk-adjusted returns with a defensive strategy. With a strong background in accounting and finance, fundamentals are a top priority. Buying a strong company with great fundamentals at an attractive price is a good long-term strategy. The subscription platform allows me to do a few things very well. It allows me to share the research I’m doing for my own investment decision making. It allows me to communicate rapidly with investors that are willing to pay for my best work.
The REIT Forum includes:
Subscriber only – Extensive research (thousands of articles) on 50+ companies, buy targets, and forward looking analysis.
Subscriber only - Weekly articles comparing 50+ preferred shares and finding the best opportunities. Preferred shares offer investors high yields with relatively lower risk.
Subscriber only - Analysis and updates on the REIT sectors. This includes finding the best investments within a subsector.
Subscriber only – Risk ratings and dividend sustainability research.
What is my view on risk?
The traditional view is to see earning excess returns as compensation for taking on high levels of risk. I believe it is far better to focus on earning returns from catching market failures. These failures happen due to poor liquidity and investors (including analysts) working with incomplete information. I believe that by knowing the individual companies well, the investor can step in when the “risk” is heavily skewed in favor of “returns”.
I do not try to generate higher returns, I try to generate more consistent returns by reducing the downwards risk. Occasionally that results in exceptionally high returns when something corrects, but it also means I am willing to pass on several decent opportunities because I want the risk/return profile skewed heavily in my favor.
Contrarian Deep Value investor from MN. I am long II Cor 5:21 and Peshach, The Lamb.... it is the best transaction and offers deepest value this side of the other side. Explore it.
Other longs, SCSS , APO (twinkies, vail, and Athene), DAVE(best BBQ chain in 'north'), plm, urre, CEF, gdxj calls, PVG, NAK, , BP , MMM, FB (yes long at 21.53, and thought is was a stupid buy when it dropped to 18... but hung on and still own those shares ;-)
Lost big time on JCP, during big CEO drop, so not all falling knives work out - yet I think that JCP will live someday, I just bought too early... ,
Since 2001, long phys gold, silver, palladium and platinum to preserve long term purchasing power. Recently added Rhodium via Kitco pool.
Long CIM, Long BP at 26.54 and watched it drop to 25, 24. ... still hold BP though, ... Long FCG,
Emerging markets, EEM, RSX, EWW (since post Trump plunge, and Early Jan'17) , and FXI.
Suggestion: Watch PLM. I have visited the site, toured the mill, and spoke personally to CEO, CFO, Pres and IR. Classic classic unloved, even hated, deep value high risk investment. It's speculative and depends on Govt permitting, so be warned. well, most of my discretionary positions are speculative.. .. except of course 2Cor5:21, .... again, that one's rock solid... one of the few you can't lose on..
Best to all, gramerw
Value investor with about 25 years experience. Im an active trader but don't trade every day. Only when I find something worth buying or selling. Tend to scale in and out of positions.
I like stocks below book value, with low PEs, turnarounds & stocks with meaningful insider buying. (Hard to find nowdays)
I think MLMs are scams and the country & world would be a better place if most were shut down and/or regulated heavily. I have no position in any of them so my opinion is not tainted by potential gains or losses. Im rooting heavily for Ackman in his quest against the evil & dishonesty of HLF.
Apparently, I own a tiny bit of NUS via FBALX. Its less than 1/10th of 1% of the fund. Kind of makes me throw up a little bit.
I am the Founder of Biotech Analysis Central, A subscription service on Seeking Alpha's Marketplace. If you want to learn more about biotech investing or you want to check out my biotech analysis you can do so with a free 2-week trial to my service. Just hit the "Learn More" button on the bottom of the Marketplace Research Tab. I have a Bachelors of Applied Science Degree In Technology Management, Industrial and Business Services Management from St. Petersburg College Florida. I have been investing in biotech stocks for many years, and I prefer to invest as a long term investor. With that In mind I seek stocks that have long term value! I primarily Like to Invest In biotechnology stocks and I accept the risks. I Write for the Healthcare Sector and Stock market in general. I contribute to Seeking Alpha, Talk Markets, and CNA Finance. I run my own biotechnology website Biotechpicklist.com
You can follow me on stocktwits.com under the name BiopharmaPro where I currently have (60,043) followers. Join me in my quest to find the best biotechnology stocks that deliver results to help patients with new treatment options. I am not afraid to find some biotech stocks to short either after results have proven a drug to be ineffective. Looking at both the negative and positive aspects of biotech investing is the best way to invest in this sector.
Peter Way Associates provides daily updated, near-term price range forecasts for over 2,000 widely-held and actively-traded stocks, ETFs and market Indexes.__
These are derived from the way market professionals protect their own capital placed at risk while helping big-money portfolio managers adjust their holdings in multi-million-dollar "block" transactions.__
Having these price-change prospects available on a continuous basis encourages individual investors to actively and economically build up the values of their own smaller portfolios. PWA only provides information for individual investors; it no longer manages investments for others.__
Rates of portfolio capital growth being achieved by subscribers are at MULTIPLES of the growth in market averages, due to the efficient use of holding period time and the compounding of gains a number of times each year.__
Risks of capital loss are protected against by insightful selection guidance and holding-period-limit disciplines. The advantages of good selection and careful timing amply cover a much smaller portion of unavoidable losses.__
These Market-maker forecasts have several decades of demonstrated productivity. Earlier in the 20th century they were used by large institutional portfolios, and now in the 21st century they are available only to individual investor wealth-building portfolios. Thousands of day-by-day identifications of specific securities having consistent, odds-on profitable results rule out any likelihood of their exceptional outcomes being due to chance. These price forecasts cannot be found elsewhere.__
Peter F. Way is a veteran Chartered Financial Analyst, having taken and passed the CFA Institute’s required 3 examinations in the first years they were given, 50+ years ago. Armed with BS in Economics from the Wharton School and an MBA degree from Harvard Business School, he has managed staffs of dozens of Investment Researchers and Quantitative Analysts for the nation’s largest bank, arbitraged index options for NYSE Specialists, and managed portfolios of hundred-million-dollar equity investments for Fortune 100 corporate pension funds and non-profit endowments. He has been elected President of professional Investment Analyst Societies in San Diego and New York City and has served on the editorial boards of the Financial Analysts Journal and the CFA Digest.
Consultant strategist with analytical expertise in implementing strategic management and creating a competitive advantage for the biopharmaceutical industry.
Decision-making methods, strategy-formulation analytical framework, and management science are extensively used to formulate and implement corporate strategies.
I'm a chartered accountant by profession, hailing from India, who is also pursuing CFA. I look for investments that generate strong value in the long run, and also help investors avoid pitfalls through my analysis.
I am a freelance author and model developer. I currently work as a consultant for a couple of select firms designing ETF asset allocation models and small-cap systems.
If your firm is looking for a research consultant on a casual or part-time basis - please reach out to me. I have some very high performing small-cap models that may interest you. I also design custom models to fit any of your needs upon request.
Contact me directly at firstname.lastname@example.org